Animation

View all stories of the same content type.

  • Management of hyperglycaemia in T2D (animation)
    Animation

    Management of hyperglycaemia in type 2 diabetes, 2018: ADA/EASD consensus report

    Commissioned by Napp Pharmaceuticals Limited

    Watch this short animation, commissioned by Napp Pharmaceuticals Limited, to find out about the third joint consensus report on the management of hyperglycaemia in type 2 diabetes by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

  • Biosimilars-animation-placeholder
    Animation

    Animation on biosimilars: opportunities, evidence, and guidance

    2018-06-07T10:10:00Z Commissioned by Napp Pharmaceuticals Limited

    This Guidelines in Practice animation has been commissioned and funded by Napp Pharmaceuticals Limited and developed in partnership with Guidelines in Practice. Napp Pharmaceuticals Limited suggested the topic for the animation, worked with MGP Ltd to choose and commission the presenter, and

  • Rifaximni-a for hepatic encephalopathy
    Animation

    Animation on the decompensated cirrhosis care bundle—the first 24 hours

    Commissioned by Norgine Pharmaceuticals Limited

    This Guidelines in Practice animation has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines in Practice.  Watch this short animation to learn about appropriate investigations that should be undertaken, and initial management and